New cell therapy aims to boost hearing restoration in cochlear implant patients
Disease control
Not yet recruiting
This early-stage trial tests a cell therapy called Rincell-1 for adults with certain types of hearing loss who are already getting a cochlear implant. About 20 participants will either receive the implant alone or with an injection of Rincell-1. The main goal is to check safety, …
Phase: PHASE1, PHASE2 • Sponsor: Rinri Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:03 UTC